Encouraging Data for Micromet's Novel Anti-Inflammatory RedNova Fri, 16 Jun 2006 12:05 PM PDT Preclinical studies have produced data which supports the potential of Micromet's investigational human antibody MT203 for the treatment of inflammatory conditions such as rheumatoid arthritis and multiple sclerosis.

Local Singer Takes Disease Battle Public 14 WFIE Evansville Fri, 16 Jun 2006 12:25 PM PDT "I don't feel cheated. I feel challenged...to not allow this to be an excuse for not doing anything." When Julie Schembre takes the stage next Friday, it will be the singer/songwriter's first Freedom Festival appearance since learning she has multiple sclerosis.

Double Whammy RedNova Sat, 17 Jun 2006 5:03 AM PDT By Nauen, Elinor Another look at MS and

A Changing Framework for MS Treatment RedNova Sat, 17 Jun 2006 5:02 AM PDT By Richert, John More choices mean more responsibility For the past 12 years we have been extremely fortunate that the PDA-approved agents for treating MS have been extraordinarily safe.

HEALTH WARMING Daily Record Sat, 17 Jun 2006 2:39 AM PDT WHETHER you are heading for a music festival, jetting off abroad or simply sitting in the park or garden, there are loads of reasons to enjoy the sun this month.

PharmaFrontiers Appoints Michael Richman to Board of Directors
RedNova Fri, 16 Jun 2006 12:06 PM PDT
PharmaFrontiers (OTCBB:PFTR), a company involved in the development and commercialization of cell therapies, today announced the appointment of Michael Richman to PharmaFrontiers' board of directors. Mr. Richman will also serve on the board's audit, compensation and nominating committees.